The idea of taking one blood test that tests for multiple cancers, a called a “liquid biopsy” in the medical-testing business, is a tempting one. If they work as promised, the tests check your blood for traces of various types of cancer before you even show any symptoms. The problem with these tests, meant as an option for very early cancer screening, is that they’re available, and even marketed directly to consumers, even though they haven’t been shown to actually be effective.
According to a lengthy exposé in The Wall Street Journal, blood testing startup Theranos is struggling to make the very technology that made founder Elizabeth Holmes America's youngest female billionaire actually work.
Blood-testing startup Theranos started from a useful idea: why are we all carrying around tiny phonecomputers in our pockets, while the basic technology behind lab tests hasn’t changed much? The company developed new equipment that uses only a few drops of blood to run standard lab tests. The startup was worth billions, and partnered wtih Walgreens for in-store blood testing centers. Then it ran into a tiny problem with health regulators: the new tests didn’t work as well as advertised.
Mr Zuckerberg made the announcement in a letter to Max on his Facebook page.
He said they are donating their fortune to the Chan Zuckerberg Initiative because they want to make the world a better place for Max to grow up in.
Mr Zuckerberg said the donation currently amounts to $45bn (£30bn).
Max was born last week, but the couple only made the news of her birth public on Tuesday.
In his letter Mr Zuckerberg said the aim of the Chan Zuckerberg Initiative is “to advance human potential and promote equality for all children in the next generation”.
I've never been afraid of needles, but giving blood is no trip to Disney World. Anytime a phlebotomist tries to sink a needle into my arm to collect blood, my plump veins roll away. Doctors stick me again and again, and I leave their offices with enough bruises on my arms to pass for a junkie.